Nivolumab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of nivolumab that may be used in the treatment of Hodgkin lymphoma (HL), T-cell lymphoma, diffuse large B-cell lymphoma (DLBCL), ampullary, appendiceal and small bowel adenocarcinoma; chronic lymphocytic leukemia (CLL); small lymphocytic lymphoma (SLL); anal, bladder, bone, hepatobiliary, colorectal, kidney, cervical, endometrial, vaginal, vulvar, head and neck, including cancer of the nasopharynx, esophageal and esophagogastric junction, squamous cell skin, small cell lung and non-small cell lung cancers; peritoneal and pleural mesothelioma, cutaneous and uveal melanoma, Merkel cell carcinoma, anaplastic thyroid carcinoma, gestational trophoblastic neoplasia (GTN), and Kaposi and soft tissue sarcoma.

**Synonyms:** - Nivolumab monotherapy - Opdivo Regimen